Explore By Subject Area   
Return Home
2025 Registration Menu

DPHARM: Disruptive Innovations

Date: Sep 16, 2025 - Sep 17, 2025

Location: Philadelphia, PA

Day Two: Wednesday, September 17, 2025
Showing Events in 1 Track from 08:00am to 08:15am
Welcome and DPHARM Idol Winner Announcement
8:00AM - 8:15AM
Welcome and DPHARM Idol Winner Announcement
Showing Events in 1 Track from 08:15am to 08:40am
Keynote
8:15AM - 8:40AM
New Insights on Optimizing the Collection of Protocol Data
Speaker:
Kenneth Getz, MBA, Executive Director and Professor, Tufts Center for the Study of Drug Development
Showing Events in 1 Track from 08:40am to 10:15am
Day Two – Morning General Session
8:40AM - 9:10AM
Disrupting Clinical Operating Models: Managing Resources to Deliver Quality, Efficiency and Speed
Moderator:
David Carruthers, VP, BioPharmaceuticals and Global Head of Clinical Operations, AstraZeneca
Panelists:
Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer
Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen
Jennifer Sheller, MPH, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck & Co., Inc.
9:10AM - 9:25AM
Accelerating Clinical Operations through Skill-Based Talent Flow
Speaker:
Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer
9:25AM - 9:55AM
Reversing the Trend of Increasing Protocol Complexity
Moderator:
Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen
Panelists:
Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS
Kenneth Getz, MBA, Executive Director and Professor, Tufts Center for the Study of Drug Development
Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist, Roche
9:55AM - 10:15AM
BeOne’s Clinical Operations and Development Journey: From Vision to Scalable Architecture
Speaker:
Melika Davis, SVP, Global Head, Clinical Operations, BeOne Medicines
Showing Events in 1 Track from 10:15am to 10:55am
Networking Break
10:15AM - 10:55AM
Networking Break
Showing Events in 1 Track from 10:55am to 11:55am
3 Track Choices: Morning Zeitgeist Track Choices
10:55AM - 11:55AM
Morning Zeitgeist Track Choices
Showing Events in 3 Tracks from 11:00am to 11:55am
Zeitgeist Track A. ROI of GenAI and Agentic AI’s Potential Impact
Track Chair:
Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo
11:00AM - 11:30AM
Generative AI: Aligning Resources with ROI
Moderator:
Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron
Panelists:
Dave Apfel, MBA, Head, External Innovation, R&D Data Science and Digital Health, Johnson & Johnson
Faisal Khan, PhD, Corporate Vice President, AI and Analytics, Novo Nordisk
Subha Madhavan, PhD, VP, Head of AI/ML, Quantitative and Digital Sciences, R&D, Pfizer
Aziz Nazha, MD, Global Head, Incyte AI Innovations Institute, Incyte
11:30AM - 11:55AM
How Agentic AI Can Revolutionize Clinical Trials Operations
Moderator:
Angela DeLuca, MBA, PMP, Associate Vice President, Head of Global Study Operations, Amgen
Panelists:
Syed Waseem Haider, PhD, Head of Business, IT Partnership for AI, Merck & Co., Inc.
Youssef Idelcaid, MBA, Head of AI Research Center [ARC], Drug Development, Gilead Sciences
Henry Wei, MD, Head of Development Innovation, Regeneron Pharmaceuticals Inc
Zeitgeist Track B. Site Engagement Strategy and Accelerating Oncology Clinical Trials
Track Chair:
Jenn Curry, Head, Patient Engagement Capabilities, Biogen
11:00AM - 11:30AM
Delivering Practical Innovations ​that Sites Want
Moderator:
Martin Hodosi, Partner, Kearney
Panelists:
Terttu Haring, MD, Global Head, Engagement Strategy, Johnson & Johnson Innovative Medicine
Mark Travers, PhD, MBA, VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.
11:30AM - 11:55AM
Expanding Access and Accelerating Oncology Clinical Trials
Moderator:
Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research
Panelists:
Laura Esserman, MD, MBA, Professor of Surgery & Radiology/Director, University of California, San Francisco/UCSF Carol Franc Buck Breast Cancer Center
Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron
Zeitgeist Track C. EHR2SPONSOR Adoption Success and Pharma 2.0 Talent Development
Track Chair:
Hassan Kadhim, Head of Business Engagement, Clinical Operations and Clinical Development, Vertex Pharmaceuticals
11:00AM - 11:30AM
From Spark to Global Impact: The eSource Revolution in Pharma
Moderator:
Amy Cramer, MMCi, BSN, Director, Data Acquisitions, IDAR, Data Management and Central Monitoring, Johnson & Johnson Innovative Medicine
Panelists:
Kristin Herman, MBA, Executive Director, Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center at Jefferson
Joseph Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center
Michele Sample, VP, Late Development Oncology Clinical Operations, AstraZeneca
11:35AM - 11:55AM
Zeitgeist Fireside: Pharma Talent Management 2.0: Accelerating Skills Readiness as Technology Innovation Disrupts Drug Development
Speaker:
Christine Vaccola, Global Development Talent Leader, Sanofi
Moderated with:
Dennis Salotti, MS, MBA, Executive Director & Head, Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
Showing Events in 1 Track from 12:00pm to 01:00pm
Today Show at DPHARM
12:00PM - 1:00PM
Today Show at DPHARM
Today Show Host:
Taras Carpiac, MBA, Executive Director, Innovation, Global Development Operations, Amgen
Showing Events in 1 Track from 01:00pm to 01:55pm
Networking Luncheon and Facilitated Roundtables
1:00PM - 1:55PM
Networking Luncheon and Facilitated Roundtables
Showing Events in 10 Tracks from 01:20pm to 01:55pm
Roundtable A
1:20PM - 1:55PM
Leveraging Patient and Site Insights to Influence Trial Design and Optimize Patient Experience
Facilitator:
Christie Fry, Director, Patient Centric Trial Design, AbbVie
Roundtable B
1:20PM - 1:55PM
Guardrails for Growth: Scaling PI Oversight with Quality at the Core
Facilitato:
Greg Manning, MS, CCRP, Head of Centralized Network Operations, Atlas Clinical Research
Roundtable C
1:20PM - 1:55PM
Informed Consent: Innovating and Collaborating Further to Decrease Patient Burden
Co-facilitators:
Katie Madden, PMP, Director, Digital Enablement, GSK
Jennifer Ribeiro, Director, Patient Recruitment and Retention Strategy, Exelixis
Roundtable D
1:20PM - 1:55PM
Evaluating the Impact of Pharma Sponsors Implementation of Site Centric Approaches
Co-facilitators:
Sylvie Kruyner, Clinical Study Manager, DCT Advisor, Bayer
Andrew Vigario, MA, Senior Clinical Country & Site Lead, Biogen
Roundtable E
1:20PM - 1:55PM
Breaking the Bottlenecks: Site Readiness, Contracting, and IRB Approval in Rare Disease Trials
Facilitator:
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Roundtable F
1:20PM - 1:55PM
Rethinking Your Buy Vs Build Strategy
Co-facilitators:
William Illis, Global Head, Collaboration and Technology Strategy, Novartis
Chris Velas, VP, Head of Digital Development, Genmab
Roundtable G
1:20PM - 1:55PM
Using Data to Optimize Clinical Trial Protocols and Accelerate Patient Recruitment
Co-facilitators:
Monica Jain, Director, R&D Data Science, Johnson & Johnson Innovative Medicine
Biswajit Kumar, Director, Programming and Data Operations, Novartis
Roundtable H
1:20PM - 1:55PM
The Collection of SOGI Data in Clinical Research
Facilitator:
Racquel Bruton, Associate Director, Clinical Trial Diversity Portfolio Lead, Biogen
Roundtable I
1:20PM - 1:55PM
Navigating the CRA Role of the Future
Facilitator:
Patrick Floody, MBA, Executive Director, Global Clinical Trials Services, Regeneron Pharmaceuticals Inc
Roundtable J
1:20PM - 1:55PM
How to Recognize and Address Bias in AI Driven Clinical Trials
Showing Events in 1 Track from 02:00pm to 05:00pm
Afternoon Track Choices
2:00PM - 5:00PM
Afternoon Track Choices
Showing Events in 4 Tracks from 02:00pm to 05:00pm
Track A: Representation in Clinical Trials, Community Site Enrollment, Site Network Value, EHR to EDC Wins, Trial Activation Strategies
Track Chair:
Eileen Hughes, RN, Senior Clinical Trial Manager, Genmab
2:00PM - 2:30PM
Ensuring Patient Representation and Access in Clinical Trials
Moderator:
Stacey Bledsoe, RN, MSN, Head of Global Clinical Trial Diversity and Inclusion, Gilead Sciences, Inc
Panelists:
Racquel Bruton, Associate Director, Clinical Trial Diversity Portfolio Lead, Biogen
Channon Monroe, MSHA, MSHE, BSN, RN, Associate Director, Diversity Program Lead, Merck
2:30PM - 2:40PM
Reserved Session
2:40PM - 3:05PM
Scaling EHR-to-EDC with Site, Sponsor, and Technology
Speakers:
Lew Klein, Senior Director - R&D IT Capability Lead, AstraZeneca
Joseph Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center
Richard Yeatman, COO, IgniteData
3:05PM - 3:15PM
Reserved Session
3:15PM - 3:40PM
Strategies to Leverage Community Networks and Amplify Oncology Patient Enrollment
Speakers:
Therese Menear, VP, Operational Excellence, Exelixis
Tracy Vanderslice, MSc, VP and Head, Clinical Operations Oncology, Gilead Sciences, Inc.
3:40PM - 4:10PM
Site Networks: Shifting from Transactional Execution to Long-Term Value
Moderator:
Adam Kinsey, Associate VP, Clinical Operations, Regional Head North America, Merck
Panelists:
Faith Gabel, Head of Project Management, Accellacare Site Network
Suvi Gross, CCRC, CEO & Co-founder, Monroe Biomedical Research
Carlos Orantes, CEO, Alcanza Clinical
Mark Scullion, CEO, Atlas Clinical Research
4:10PM - 4:40PM
Novel Approaches to Accelerate Trial Activation Timelines
Moderator:
Brian Mitchell, US Director of Development Operations & Acting US Regional Head Global Study Operations, Amgen
Panelists:
Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS
Andrew Vigario, MA, Senior Clinical Country & Site Lead, Biogen
Adrienne Walstrum, MSc, Senior Director, Global Trial Optimization, Merck
4:40PM - 5:00PM
Expanding Patient Access with a Community Sites Model
Speakers:
Mimi Fenton, PhD, MPH, Chief Executive Officer, Cedar Health Research
Timothy Joy, Head, Clinical Operations Strategic Solutions, Pfizer
Track B: Digital Transformation, End-to-End Solutions, Global Tokenization, Regulatory Hurdles to Digital Endpoints
Track Chair:
Lauren Sunshine, Director, Product Management, Digital Health, BMS
2:00PM - 2:40PM
Advancing Digital Transformation
Moderators:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Isaac R Rodriguez-Chavez, PhD, MHS, MS, Principal Independent Consultant & Co-chair, 4Biosolutions Consulting/IEEE-SA-DCT/DHT Program
Panelists:
Rinol Alaj, MS, MPH, MBA, Head of Digital Health Technologies, Regeneron
Michelle Crouthamel, PhD, Head, Digital Science, AbbVie
Carrie Northcott, PhD, Head of Digital Sciences, Pfizer Inc.
2:40PM - 2:50PM
Reserved Session
2:50PM - 3:15PM
End-to-End Tech Solutions: Bridging Planning and Delivery at Moderna
Speakers:
Sergey Krymgold, MS, Executive Director, Development Systems and Data Strategy, Moderna
Axel Wiest, VP, Head of Portfolio & Program Management, Moderna Therapeutics
3:15PM - 3:45PM
Leveraging Tokenization Globally: Opportunities and Challenges
Moderator:
Tom Dougherty, Data Science and AI Innovative Partnership Lead, Novo Nordisk
Panelists:
Carissa Dukes, MPH, Director, Global Epidemiology & RWE, Boehringer Ingelheim
Biswajit Kumar, Director, Programming and Data Operations, Novartis
Kevin Rutty, Director, Group Lead, Clinical Data & Information Sciences, Pfizer
3:45PM - 4:15PM
Addressing Barriers to Regulatory Acceptance of Novel Digital Measures
Panelists:
Carrie Northcott, PhD, Head of Digital Sciences, Pfizer Inc.
4:15PM - 4:40PM
Accelerate Decision-making with a Semantic Intelligence Platform for End-to-End Drug Development
Speakers:
Venky Iyer, Director, Clinical Data and Information Services, Pfizer
Sheraz Khan, PhD, Director, Data Science,, Pfizer
4:40PM - 5:00PM
Integrating HCP/HCO Data with RWD to Bring Clinical Trials Closer to Patients
Speaker:
Preeti Chawla, Data Domain Owner, Boehringer Ingelheim
Track C. Track Protocol Digitization, Patient Matching, In-life Trial Enrollment Reforecasting, AI Powered Audit Trails, Polygenic Risk Scores
Track Chair:
Rucha Shah, Lived-experience Expert, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
2:00PM - 2:25PM
Protocol Digitization to Accelerate Development Timelines
Moderator:
William Illis, Global Head, Collaboration and Technology Strategy, Novartis
Panelists:
Neha Begum, Associate Director, Drug Development IT, BMS
Vivian Combs, MS, Director, Scientific Communications, Diabetes Business Unit, Eli Lilly and Company
2:25PM - 2:55PM
Clinical Trial Patient Matching in 2025 - State of the Union
Speakers:
Sean Lynch, Innovative Capabilities Head, Innovative Trial Operations, Novartis
Alyssa Tarantino, Innovation Lead, BMS
2:55PM - 3:05PM
Reserved Session
3:05PM - 3:25PM
Leveraging In-life Trial Enrollment Reforecasting for Operational Decision-making at Vertex
Speaker:
Sara Kohnke, PhD, Senior Data Scientist, Vertex Pharmaceuticals
3:25PM - 3:35PM
Reserved Session
3:35PM - 3:55PM
Digitizing Public Clinical Trial Protocols for Data-Driven Trial Design
Speaker:
Kelly Hoang, PhD, Associate Director, Data Scientist, Gilead Sciences
3:55PM - 4:15PM
Embedding Genomics to Improve Costs and Efficiencies in Clinical Trials
Speaker:
Shameer Khader, PhD, MPH, Executive Director, Sanofi
4:15PM - 4:35PM
Deploying AI to Streamline Audit Trail Reviews
Speaker:
Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals
4:35PM - 4:55PM
Integrating Patient Insights Early on to Increase Global Patient Enrollment
Speaker:
Anna Osinski, Associate Director, Patient Centricity and Engagment Development Unit Lead, Biogen
Track D: Innovating with Less for Biotechs: Resourceful Approaches to Deploying Clinical Trial Innovation
Track Chair:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
2:00PM - 2:05PM
Co-Chair Opening Remarks
Speaker:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
2:05PM - 2:45PM
Adapting Operating Models to Meet the Urgent Need for Speed in Clinical Development
Moderator:
Tara Aldoory, VP, Head of Clinical Trial Delivery, Biogen
Panelists:
Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab
Marie Rosenfeld, SVP, Clinical Operations and Data Management, Entrada Therapuetics
2:45PM - 3:25PM
Setting your Strategy for Adopting AI and Emerging Tech Solutions
Speakers:
Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals
Paulius Ojeras, Head of Clinical Operations, Perceive Biotherapeutics
Chris Velas, VP, Head of Digital Development, Genmab
3:25PM - 3:55PM
Preparing for Tomorrow’s Skill Set for Clinical Operations
Moderator:
Alice Donnelly, SVP, Clinical Operations, Alnylam
Panelists:
Mary Brantner, Senior Director, Clinical Program Optimization and Innovation, Insmed Incorporated
Charlie Semenchuk, Sr Director - Head of GCDO Business & Technology Capabilities, Jazz Pharmaceuticals
3:55PM - 4:25PM
Effective Vendor Partnership Strategies and Governance on a Budget
Speakers:
Melanie Goodwin, Director, Clinical Outsourcing, Immunocore
Erin Jacques, Associate Director, Clinical Vendor Alliance Management, Insmed
4:25PM - 4:55PM
Resourceful Patient Recruitment Strategies for Rare Disease
Moderator:
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Panelists:
Kristin Blouch, MSc Precision Medicine, Director, Senior Patient Recruitment and Retention Strategy, Exelixis
Jenn Curry, Head, Patient Engagement Capabilities, Biogen
Amanda Decoker, Senior Director, Patient Recruitment and Retention, Takeda
Maureen Quinn, MBA, Manager, Patient Recruitment and Retention, Moderna
4:55PM - 5:00PM
Closing Remarks
Speaker:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
Showing Events in 1 Track from 05:00pm to 05:00pm
DPHARM 2025 Concludes
5:00PM - 5:00PM
DPHARM 2025 Concludes
Showing Events in 1 Track from 08:00am to 08:15am
Welcome and DPHARM Idol Winner Announcement
8:00AM - 8:15AM
Welcome and DPHARM Idol Winner Announcement
Showing Events in 1 Track from 08:15am to 08:40am
Keynote
8:15AM - 8:40AM
New Insights on Optimizing the Collection of Protocol Data
Speaker:
Kenneth Getz, MBA, Executive Director and Professor, Tufts Center for the Study of Drug Development
Showing Events in 1 Track from 08:40am to 10:15am
Day Two – Morning General Session
8:40AM - 9:10AM
Disrupting Clinical Operating Models: Managing Resources to Deliver Quality, Efficiency and Speed
Moderator:
David Carruthers, VP, BioPharmaceuticals and Global Head of Clinical Operations, AstraZeneca
Panelists:
Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer
Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen
Jennifer Sheller, MPH, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck & Co., Inc.
9:10AM - 9:25AM
Accelerating Clinical Operations through Skill-Based Talent Flow
Speaker:
Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer
9:25AM - 9:55AM
Reversing the Trend of Increasing Protocol Complexity
Moderator:
Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen
Panelists:
Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS
Kenneth Getz, MBA, Executive Director and Professor, Tufts Center for the Study of Drug Development
Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist, Roche
9:55AM - 10:15AM
BeOne’s Clinical Operations and Development Journey: From Vision to Scalable Architecture
Speaker:
Melika Davis, SVP, Global Head, Clinical Operations, BeOne Medicines
Showing Events in 1 Track from 10:15am to 10:55am
Networking Break
10:15AM - 10:55AM
Networking Break
Showing Events in 1 Track from 10:55am to 11:55am
3 Track Choices: Morning Zeitgeist Track Choices
10:55AM - 11:55AM
Morning Zeitgeist Track Choices
Showing Events in 3 Tracks from 11:00am to 11:55am
Zeitgeist Track A. ROI of GenAI and Agentic AI’s Potential Impact
Track Chair:
Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo
11:00AM - 11:30AM
Generative AI: Aligning Resources with ROI
Moderator:
Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron
Panelists:
Dave Apfel, MBA, Head, External Innovation, R&D Data Science and Digital Health, Johnson & Johnson
Faisal Khan, PhD, Corporate Vice President, AI and Analytics, Novo Nordisk
Subha Madhavan, PhD, VP, Head of AI/ML, Quantitative and Digital Sciences, R&D, Pfizer
Aziz Nazha, MD, Global Head, Incyte AI Innovations Institute, Incyte
11:30AM - 11:55AM
How Agentic AI Can Revolutionize Clinical Trials Operations
Moderator:
Angela DeLuca, MBA, PMP, Associate Vice President, Head of Global Study Operations, Amgen
Panelists:
Syed Waseem Haider, PhD, Head of Business, IT Partnership for AI, Merck & Co., Inc.
Youssef Idelcaid, MBA, Head of AI Research Center [ARC], Drug Development, Gilead Sciences
Henry Wei, MD, Head of Development Innovation, Regeneron Pharmaceuticals Inc
Zeitgeist Track B. Site Engagement Strategy and Accelerating Oncology Clinical Trials
Track Chair:
Jenn Curry, Head, Patient Engagement Capabilities, Biogen
11:00AM - 11:30AM
Delivering Practical Innovations ​that Sites Want
Moderator:
Martin Hodosi, Partner, Kearney
Panelists:
Terttu Haring, MD, Global Head, Engagement Strategy, Johnson & Johnson Innovative Medicine
Mark Travers, PhD, MBA, VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.
11:30AM - 11:55AM
Expanding Access and Accelerating Oncology Clinical Trials
Moderator:
Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research
Panelists:
Laura Esserman, MD, MBA, Professor of Surgery & Radiology/Director, University of California, San Francisco/UCSF Carol Franc Buck Breast Cancer Center
Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron
Zeitgeist Track C. EHR2SPONSOR Adoption Success and Pharma 2.0 Talent Development
Track Chair:
Hassan Kadhim, Head of Business Engagement, Clinical Operations and Clinical Development, Vertex Pharmaceuticals
11:00AM - 11:30AM
From Spark to Global Impact: The eSource Revolution in Pharma
Moderator:
Amy Cramer, MMCi, BSN, Director, Data Acquisitions, IDAR, Data Management and Central Monitoring, Johnson & Johnson Innovative Medicine
Panelists:
Kristin Herman, MBA, Executive Director, Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center at Jefferson
Joseph Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center
Michele Sample, VP, Late Development Oncology Clinical Operations, AstraZeneca
11:35AM - 11:55AM
Zeitgeist Fireside: Pharma Talent Management 2.0: Accelerating Skills Readiness as Technology Innovation Disrupts Drug Development
Speaker:
Christine Vaccola, Global Development Talent Leader, Sanofi
Moderated with:
Dennis Salotti, MS, MBA, Executive Director & Head, Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
Showing Events in 1 Track from 12:00pm to 01:00pm
Today Show at DPHARM
12:00PM - 1:00PM
Today Show at DPHARM
Today Show Host:
Taras Carpiac, MBA, Executive Director, Innovation, Global Development Operations, Amgen
Showing Events in 1 Track from 01:00pm to 01:55pm
Networking Luncheon and Facilitated Roundtables
1:00PM - 1:55PM
Networking Luncheon and Facilitated Roundtables
Showing Events in 10 Tracks from 01:20pm to 01:55pm
Roundtable A
1:20PM - 1:55PM
Leveraging Patient and Site Insights to Influence Trial Design and Optimize Patient Experience
Facilitator:
Christie Fry, Director, Patient Centric Trial Design, AbbVie
Roundtable B
1:20PM - 1:55PM
Guardrails for Growth: Scaling PI Oversight with Quality at the Core
Facilitato:
Greg Manning, MS, CCRP, Head of Centralized Network Operations, Atlas Clinical Research
Roundtable C
1:20PM - 1:55PM
Informed Consent: Innovating and Collaborating Further to Decrease Patient Burden
Co-facilitators:
Katie Madden, PMP, Director, Digital Enablement, GSK
Jennifer Ribeiro, Director, Patient Recruitment and Retention Strategy, Exelixis
Roundtable D
1:20PM - 1:55PM
Evaluating the Impact of Pharma Sponsors Implementation of Site Centric Approaches
Co-facilitators:
Sylvie Kruyner, Clinical Study Manager, DCT Advisor, Bayer
Andrew Vigario, MA, Senior Clinical Country & Site Lead, Biogen
Roundtable E
1:20PM - 1:55PM
Breaking the Bottlenecks: Site Readiness, Contracting, and IRB Approval in Rare Disease Trials
Facilitator:
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Roundtable F
1:20PM - 1:55PM
Rethinking Your Buy Vs Build Strategy
Co-facilitators:
William Illis, Global Head, Collaboration and Technology Strategy, Novartis
Chris Velas, VP, Head of Digital Development, Genmab
Roundtable G
1:20PM - 1:55PM
Using Data to Optimize Clinical Trial Protocols and Accelerate Patient Recruitment
Co-facilitators:
Monica Jain, Director, R&D Data Science, Johnson & Johnson Innovative Medicine
Biswajit Kumar, Director, Programming and Data Operations, Novartis
Roundtable H
1:20PM - 1:55PM
The Collection of SOGI Data in Clinical Research
Facilitator:
Racquel Bruton, Associate Director, Clinical Trial Diversity Portfolio Lead, Biogen
Roundtable I
1:20PM - 1:55PM
Navigating the CRA Role of the Future
Facilitator:
Patrick Floody, MBA, Executive Director, Global Clinical Trials Services, Regeneron Pharmaceuticals Inc
Roundtable J
1:20PM - 1:55PM
How to Recognize and Address Bias in AI Driven Clinical Trials
Showing Events in 1 Track from 02:00pm to 05:00pm
Afternoon Track Choices
2:00PM - 5:00PM
Afternoon Track Choices
Showing Events in 4 Tracks from 02:00pm to 05:00pm
Track A: Representation in Clinical Trials, Community Site Enrollment, Site Network Value, EHR to EDC Wins, Trial Activation Strategies
Track Chair:
Eileen Hughes, RN, Senior Clinical Trial Manager, Genmab
2:00PM - 2:30PM
Ensuring Patient Representation and Access in Clinical Trials
Moderator:
Stacey Bledsoe, RN, MSN, Head of Global Clinical Trial Diversity and Inclusion, Gilead Sciences, Inc
Panelists:
Racquel Bruton, Associate Director, Clinical Trial Diversity Portfolio Lead, Biogen
Channon Monroe, MSHA, MSHE, BSN, RN, Associate Director, Diversity Program Lead, Merck
2:30PM - 2:40PM
Reserved Session
2:40PM - 3:05PM
Scaling EHR-to-EDC with Site, Sponsor, and Technology
Speakers:
Lew Klein, Senior Director - R&D IT Capability Lead, AstraZeneca
Joseph Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center
Richard Yeatman, COO, IgniteData
3:05PM - 3:15PM
Reserved Session
3:15PM - 3:40PM
Strategies to Leverage Community Networks and Amplify Oncology Patient Enrollment
Speakers:
Therese Menear, VP, Operational Excellence, Exelixis
Tracy Vanderslice, MSc, VP and Head, Clinical Operations Oncology, Gilead Sciences, Inc.
3:40PM - 4:10PM
Site Networks: Shifting from Transactional Execution to Long-Term Value
Moderator:
Adam Kinsey, Associate VP, Clinical Operations, Regional Head North America, Merck
Panelists:
Faith Gabel, Head of Project Management, Accellacare Site Network
Suvi Gross, CCRC, CEO & Co-founder, Monroe Biomedical Research
Carlos Orantes, CEO, Alcanza Clinical
Mark Scullion, CEO, Atlas Clinical Research
4:10PM - 4:40PM
Novel Approaches to Accelerate Trial Activation Timelines
Moderator:
Brian Mitchell, US Director of Development Operations & Acting US Regional Head Global Study Operations, Amgen
Panelists:
Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS
Andrew Vigario, MA, Senior Clinical Country & Site Lead, Biogen
Adrienne Walstrum, MSc, Senior Director, Global Trial Optimization, Merck
4:40PM - 5:00PM
Expanding Patient Access with a Community Sites Model
Speakers:
Mimi Fenton, PhD, MPH, Chief Executive Officer, Cedar Health Research
Timothy Joy, Head, Clinical Operations Strategic Solutions, Pfizer
Track B: Digital Transformation, End-to-End Solutions, Global Tokenization, Regulatory Hurdles to Digital Endpoints
Track Chair:
Lauren Sunshine, Director, Product Management, Digital Health, BMS
2:00PM - 2:40PM
Advancing Digital Transformation
Moderators:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Isaac R Rodriguez-Chavez, PhD, MHS, MS, Principal Independent Consultant & Co-chair, 4Biosolutions Consulting/IEEE-SA-DCT/DHT Program
Panelists:
Rinol Alaj, MS, MPH, MBA, Head of Digital Health Technologies, Regeneron
Michelle Crouthamel, PhD, Head, Digital Science, AbbVie
Carrie Northcott, PhD, Head of Digital Sciences, Pfizer Inc.
2:40PM - 2:50PM
Reserved Session
2:50PM - 3:15PM
End-to-End Tech Solutions: Bridging Planning and Delivery at Moderna
Speakers:
Sergey Krymgold, MS, Executive Director, Development Systems and Data Strategy, Moderna
Axel Wiest, VP, Head of Portfolio & Program Management, Moderna Therapeutics
3:15PM - 3:45PM
Leveraging Tokenization Globally: Opportunities and Challenges
Moderator:
Tom Dougherty, Data Science and AI Innovative Partnership Lead, Novo Nordisk
Panelists:
Carissa Dukes, MPH, Director, Global Epidemiology & RWE, Boehringer Ingelheim
Biswajit Kumar, Director, Programming and Data Operations, Novartis
Kevin Rutty, Director, Group Lead, Clinical Data & Information Sciences, Pfizer
3:45PM - 4:15PM
Addressing Barriers to Regulatory Acceptance of Novel Digital Measures
Panelists:
Carrie Northcott, PhD, Head of Digital Sciences, Pfizer Inc.
4:15PM - 4:40PM
Accelerate Decision-making with a Semantic Intelligence Platform for End-to-End Drug Development
Speakers:
Venky Iyer, Director, Clinical Data and Information Services, Pfizer
Sheraz Khan, PhD, Director, Data Science,, Pfizer
4:40PM - 5:00PM
Integrating HCP/HCO Data with RWD to Bring Clinical Trials Closer to Patients
Speaker:
Preeti Chawla, Data Domain Owner, Boehringer Ingelheim
Track C. Track Protocol Digitization, Patient Matching, In-life Trial Enrollment Reforecasting, AI Powered Audit Trails, Polygenic Risk Scores
Track Chair:
Rucha Shah, Lived-experience Expert, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
2:00PM - 2:25PM
Protocol Digitization to Accelerate Development Timelines
Moderator:
William Illis, Global Head, Collaboration and Technology Strategy, Novartis
Panelists:
Neha Begum, Associate Director, Drug Development IT, BMS
Vivian Combs, MS, Director, Scientific Communications, Diabetes Business Unit, Eli Lilly and Company
2:25PM - 2:55PM
Clinical Trial Patient Matching in 2025 - State of the Union
Speakers:
Sean Lynch, Innovative Capabilities Head, Innovative Trial Operations, Novartis
Alyssa Tarantino, Innovation Lead, BMS
2:55PM - 3:05PM
Reserved Session
3:05PM - 3:25PM
Leveraging In-life Trial Enrollment Reforecasting for Operational Decision-making at Vertex
Speaker:
Sara Kohnke, PhD, Senior Data Scientist, Vertex Pharmaceuticals
3:25PM - 3:35PM
Reserved Session
3:35PM - 3:55PM
Digitizing Public Clinical Trial Protocols for Data-Driven Trial Design
Speaker:
Kelly Hoang, PhD, Associate Director, Data Scientist, Gilead Sciences
3:55PM - 4:15PM
Embedding Genomics to Improve Costs and Efficiencies in Clinical Trials
Speaker:
Shameer Khader, PhD, MPH, Executive Director, Sanofi
4:15PM - 4:35PM
Deploying AI to Streamline Audit Trail Reviews
Speaker:
Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals
4:35PM - 4:55PM
Integrating Patient Insights Early on to Increase Global Patient Enrollment
Speaker:
Anna Osinski, Associate Director, Patient Centricity and Engagment Development Unit Lead, Biogen
Track D: Innovating with Less for Biotechs: Resourceful Approaches to Deploying Clinical Trial Innovation
Track Chair:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
2:00PM - 2:05PM
Co-Chair Opening Remarks
Speaker:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
2:05PM - 2:45PM
Adapting Operating Models to Meet the Urgent Need for Speed in Clinical Development
Moderator:
Tara Aldoory, VP, Head of Clinical Trial Delivery, Biogen
Panelists:
Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab
Marie Rosenfeld, SVP, Clinical Operations and Data Management, Entrada Therapuetics
2:45PM - 3:25PM
Setting your Strategy for Adopting AI and Emerging Tech Solutions
Speakers:
Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals
Paulius Ojeras, Head of Clinical Operations, Perceive Biotherapeutics
Chris Velas, VP, Head of Digital Development, Genmab
3:25PM - 3:55PM
Preparing for Tomorrow’s Skill Set for Clinical Operations
Moderator:
Alice Donnelly, SVP, Clinical Operations, Alnylam
Panelists:
Mary Brantner, Senior Director, Clinical Program Optimization and Innovation, Insmed Incorporated
Charlie Semenchuk, Sr Director - Head of GCDO Business & Technology Capabilities, Jazz Pharmaceuticals
3:55PM - 4:25PM
Effective Vendor Partnership Strategies and Governance on a Budget
Speakers:
Melanie Goodwin, Director, Clinical Outsourcing, Immunocore
Erin Jacques, Associate Director, Clinical Vendor Alliance Management, Insmed
4:25PM - 4:55PM
Resourceful Patient Recruitment Strategies for Rare Disease
Moderator:
Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin
Panelists:
Kristin Blouch, MSc Precision Medicine, Director, Senior Patient Recruitment and Retention Strategy, Exelixis
Jenn Curry, Head, Patient Engagement Capabilities, Biogen
Amanda Decoker, Senior Director, Patient Recruitment and Retention, Takeda
Maureen Quinn, MBA, Manager, Patient Recruitment and Retention, Moderna
4:55PM - 5:00PM
Closing Remarks
Speaker:
Murray Abramson, Chief Development Officer, Ascidian Therapeutics
Showing Events in 1 Track from 05:00pm to 05:00pm
DPHARM 2025 Concludes
5:00PM - 5:00PM
DPHARM 2025 Concludes
Next
Day Two
Wednesday, September 17, 2025

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.